Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Financial Services & Investing
Banking
Stock Market
Managed Health Care
Alternative Energy
International News
Computer Apps, Software & OS
Science
Corporate News
Internet Media, Content & Design
Table bottom

Alzheimers
Skyhawk Therapeutics, Inc. ("Skyhawk"), a new private company focused on the discovery and development of small molecule therapeutics that correct RNA expression, today announced the close of $8 million in seed funding led by major family and...
PR Newswire, 10:08am ET



Rare Pediatric Disease Designation and Regenerative Medicine Advanced Therapy designations provide regulatory framework to advance ESS' path to market Via OTC PR Wire -- Amarantus Bioscience Holdings, Inc. (OTCPK:AMBS), a US-based...
GlobeNewswire, 10:03am ET

The Alzheimer's Foundation of America (AFA) heralded the signing of the new RAISE Family Caregiver Act, which will provide a desperately needed comprehensive national plan for the millions of family caregivers across the country who tirelessly...
GlobeNewswire, 9:58am ET

The early results of mesenchymal stem cells studies look encouraging for lessening or reversing the effects of Aging Frailty, Joshua M. Hare, M.D., Director of the Interdisciplinary Stem Cell Institute at the University of Miami Miller School of...
PR Newswire, 9:08am ET

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that validation has completed and the opposition period expired for European Patent Number 2591359,...
PR Newswire, 8:28am ET

InnerScope Hearing Technologies Inc. (OTCQB: INND) announced the successful launch of Hearingbenefit.com, a website for its Personal Sound Amplifier Products (PSAPs), as part of the company's e-commerce direct-to-consumer sales funnel strategy....
PR Newswire, 8:09am ET

MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - January 23, 2018) - Oryzon to present for the first time at NobleCon14, Noble Capital Markets' Fourteenth Annual Investor Conference in Fort Lauderdale, Florida Oryzon to present at...
Marketwired, 8:08am ET

LONDON, UK / ACCESSWIRE / January 23, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Medical Diagnostics & Research industry: ProMIS Neurosciences, Spectral Medical, GeneNews,...
ACCESSWIRE, 8:08am ET

MADRID, SPAIN and CAMBRIDGE, MA--(Marketwired - January 23, 2018) - Oryzon to present for the first time at NobleCon14, Noble Capital Markets' Fourteenth Annual Investor Conference in Fort Lauderdale, Florida Oryzon to present at...
Marketwire Canada, 8:08am ET

Women Who Tech, a U.S.-based nonprofit that advocates to close the funding gap for women in the technology and startup industry, today announced the 10 finalists selected for the sixth Women Startup Challenge who will pitch their startup in a...
PR Newswire, 7:53am ET

Humanized PMN310 Shows Significantly Greater Binding to The Toxic Oligomer Fraction of Alzheimer's Disease Brain Extract Compared to Aducanumab TORONTO and CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc....
Globe Newswire, 7:38am ET

Humanized PMN310 Shows Significantly Greater Binding to The Toxic Oligomer Fraction of Alzheimer's Disease Brain Extract Compared to Aducanumab ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development...
CNW Group, 7:38am ET

Humanized PMN310 Shows Significantly Greater Binding to The Toxic Oligomer Fraction of Alzheimer's Disease Brain Extract Compared to Aducanumab ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development...
PR Newswire, 7:38am ET

Alkahest, Inc. ("Alkahest"), a clinical-stage biotechnology company focused on developing new treatments for neurodegenerative diseases and other age-related conditions, announced today the appointments of Karl G. Trass as Vice President,...
PR Newswire, 7:08am ET

Voyager Therapeutics, Inc. (NASDAQ:VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today announced that the U.S. Food and Drug Administration (FDA) has cleared the...
GlobeNewswire, 7:08am ET

Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent Application 12/948,828, "Methods and compositions for treating symptoms...
GlobeNewswire, 7:08am ET

Freshman guard Kelsey Marshall surveys the floor for an open teammate in a matchup against the Syracuse Orange. Miami would go on to win 72-67 on Jan. 18 at the Watsco Center. Photo credit: Josh White Kelsey Marshall isn't fazed by high...
University Wire, 3:08am ET

1-17 of 17


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.